Equillium Announces Initiation of the EQUIP Phase 1b Clinical Trial of Itolizumab for Patients with Uncontrolled Asthma

NEXT STORY
BeyondSpring Provides Operational Update and First Quarter 2019 Financial Results
PREV STORY
XBiotech Adds Dr. Peter Libby, Renowned Cardiologist and Research Pioneer in Inflammation and Cardiovascular Disease, to its Corporate Board
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global Disposable Endoscopes Market 2014-2019 & 2025 – Major Players are Ambu A/S, Boston Scientific, and OBP Medical

author_avatar
NASDAQ Market News

Sensus Healthcare to Participate in Three Investment Conferences During the Month of March

author_avatar
NASDAQ Market News

BioCryst’s RAPIVAB® (peramivir injection) Receives FDA Approval for a Pediatric Indication

RESEARCH TRIANGLE PARK, N.C., Sept. 21, 2017 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) ...

author_avatar
NASDAQ Market News